Abstract
Background Aortic valve stenosis is associated with age, rheumatic fever, and bicuspid aortic valve but its association with other comorbidities such as inflammatory disease and race is less known. The purpose of this study was to investigate any association between aortic stenosis and many comorbidities.
Method We utilized the large Nationwide Inpatient Sample database to evaluate any association between aortic stenosis and risk factors. We performed uni- and multivariate analyses adjusting for comorbid conditions.
Results Data were extracted from the first available database that used ICD-10 codes specifically coding for aortic stenosis alone, spanning from 2016 to 2020. Data included 112,982,565 patients. A total of 2,322,649 had aortic stenosis, with the remaining 110,659,916 patients serving as controls. We found a strong and independent significant association between aortic stenosis and coronary artery disease (OR: 2.11, CI 2.09 - 2.13, P < 0.001), smoking (OR: 1.08, CI 1.07 - 1.08, P < 0.001), diabetes mellitus (OR: 1.15, CI 1.14 - 1.16, P < 0.001), hypertension (OR: 1.41, CI 1.4 - 1.43, P < 0.001), hyperlipidemia (OR: 1.31, CI 1.3 - 1.32, P < 0.001), renal disease (OR: 1.3, CI 1.29 - 1.31, P < 0.001), chronic obstructive lung disease (COPD) (OR: 1.05, CI 1.04 - 1.05, P < 0.001), obesity (OR: 1.3, CI 1.29 -1.32, P < 0.001), rheumatoid arthritis (OR: 1.13, CI 1.11 - 1.15, P <0.001), scleroderma (OR: 1.93, CI 1.79 - 2.09, P <0.001), systemic connective tissue disease (OR: 1.24, CI 1.2 - 1.27, P <0.001), polyarteritis nodosa (OR: 1.5, CI 1.24 -1.81, P <0.001), and Raynauds syndrome (OR: 1.16, CI 1.09 - 1.24, P <0.001), in addition to known factors such as age, male gender and bicuspid aortic valve.
Conclusion Using a very large database, we found many new associations for presence of aortic valve stenosis including race, renal disease, several inflammatory diseases, COPD, and obesity in addition to many other known cardiovascular risk factors.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
None
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Used NIS data base
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
